Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.18 +0.28 (+1.12%)
Official Closing Price Updated: 7:00 PM EST, Jan 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
2 No-Brainer Healthcare Stocks to Buy Now ↗
These two healthcare stocks scan as bargains right now. 
Via The Motley Fool
News headline image
Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Pfizer (NYSE:PFE)
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, including Pfizer (NYSE:PFE) and its peers. 
Via StockStory
Topics Artificial Intelligence Intellectual Property
News headline image
Pfizer's CEO Sends a Warning to Eli Lilly. Is the Stock a Buy? ↗
Pfizer's weight management pipeline just got a boost. 
Via The Motley Fool
News headline image
Explore the S&P500 index on Monday and find out which stocks are the most active in today's session. ↗
Looking for the most active stocks in the S&P500 index on Monday? Dive into today's session and discover the stocks that are dominating the trading activity and setting the pace for the market. 
Via Chartmill
News headline image
Valuation Fears Ignite "Great Rotation" in Global Markets as Investors Seek Shelter from Elevated Prices
Global financial markets are currently gripped by a palpable sense of unease, as elevated valuations, particularly within the high-flying technology and Artificial Intelligence (AI) sectors, spark... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Novo Nordisk's New Chair Aims To Reinforce Board As Foundation Tightens Control ↗
Novo Nordisk's new chair Lars Sorensen plans to add pharma expertise and address governance concerns after a major board overhaul backed by the company's foundation. 
Via Benzinga
News headline image
2 Giant Healthcare Stocks to Buy Hand Over Fist in November ↗
Consider buying Medtronic for its dividend and Pfizer for its turnaround potential if you are looking for attractive healthcare investments in November. 
Via The Motley Fool
News headline image
Johnson & Johnson Inks A $3.05 Billion Deal In Cancer Treatment ↗
Johnson & Johnson said Monday it's putting up $3.05 billion to buy privately held cancer player Halda Therapeutics. 
Via Investor's Business Daily
News headline image
This Sector Is Suddenly Crushing the Broader Market. Should You Invest $1,000? ↗
Healthcare stocks have far outperformed the broader market over the past month. 
Via The Motley Fool
Topics ETFs Government World Trade
News headline image
Down 55%, Should You Buy the Dip on Pfizer? ↗
Pfizer is a pharmaceutical industry giant facing normal pharmaceutical industry headwinds; it will survive. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Michael Burry Bets Against Nvidia and Palantir. But It's Not What You Think. ↗
Burry bought $1.1 billion of put options in these stocks. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Is Pfizer Stock a Buy After This $10 Billion Acquisition? ↗
The company has been on an acquisition spree for years, and this one may be the most important yet. 
Via The Motley Fool
Topics Intellectual Property Lawsuit
News headline image
Healthcare Sector Navigates Mixed Market Close: A Beacon of Stability Amidst Uncertainty
As the broader market concluded with a mixed performance on November 14, 2025, the S&P 500 Healthcare sector once again underscored its often-defensive nature, demonstrating resilience amidst an... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Deal Dispatch: Warner Bros., Bill.com, C3 AI—Key Auctions And Buyouts Shake The Market ↗
Paramount, Comcast, Netflix, Clearlake, Blackstone, and others drive major M&A activity. On the sell side are WBD, Bill.com and TuneIn. 
Via Benzinga
News headline image
Fear Of An AI Bubble? This Sector Is Quietly Surging While Tech Sinks ↗
While AI stocks slide, healthcare is soaring. XLV leads November gains, outperforming tech as investors rotate. 
Via Benzinga
Topics Artificial Intelligence
News headline image
AI Revolutionizes Drug Shelf-Life: Optimized Stability Models Promise Safer, More Effective Medicines
The pharmaceutical industry is on the cusp of a profound transformation, driven by the integration of data science and Artificial Intelligence (AI) into drug formulation stability models. This... 
Via TokenRing AI
Topics Artificial Intelligence Economy Product Recall
News headline image
AI Revolutionizes Medicine: Precision Bioanalysis and Targeted Delivery Usher in a New Era of Healthcare
The convergence of artificial intelligence (AI) with advanced bioanalysis and targeted drug delivery technologies is fundamentally reshaping the landscape of medicine and healthcare. These synergistic... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
What's going on in today's session: S&P500 most active stocks ↗
Looking for the most active S&P500 stocks in today's session? Join us as we dive into the US markets on Friday and discover the stocks that are dominating the trading activity and setting the pace for... 
Via Chartmill
News headline image
Biopharma Boom: M&A Frenzy, AI Revolution, and GLP-1 Gold Rush Drive Robust Growth in 2025
The pharmaceutical and biotechnology sectors are experiencing a period of significant dynamism and robust growth as of November 2025, fueled by a confluence of scientific advancements, a resurgence in... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Eli Lilly Strikes Deal With Trump: Why Shares Are Up 10% Since ↗
Via MarketBeat
News headline image
Why Pfizer (PFE) Shares Are Sliding Today
Shares of global pharmaceutical company Pfizer (NYSE:PFE) fell 2.5% in the morning session after the company cut its stake in its pandemic partner BioNTech by more than half, a move that overshadowed... 
Via StockStory
Topics Artificial Intelligence Stocks Supply Chain
News headline image
Ozempic Maker Novo Nordisk Faces Board Shakeup ↗
Novo Nordisk faces board changes, investor friction and bold M&A moves as leadership pushes to regain momentum in the obesity drug market. 
Via Benzinga
News headline image
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks Delivering High-Dividend Yields ↗
 
Via Benzinga
News headline image
Novo Nordisk Stock Falls Premarket As Investors Brace For Contentious Vote To Reinstate Former CEO ↗
The board overhaul follows mass resignations triggered by internal disputes over Novo’s direction. 
Via Stocktwits
News headline image
Pfizer Stock Slips Premarket Despite Completing Metsera Deal; Investors React To BioNTech Stake Cut ↗
The Metsera buyout brings multiple obesity and cardiometabolic drug candidates into Pfizer’s pipeline, including a GLP-1 nearing Phase 3. 
Via Stocktwits
Topics Intellectual Property
Cidara Therapeutics Stock Soars 42% After-Hours On Merck Buyout Buzz — Retail Traders Eye A Potential Blowout Premium ↗
Via Stocktwits
News headline image
AI Revolutionizes Cardiovascular Clinical Trials: A Leap Towards Cheaper, Faster Drug Development
San Francisco, CA – November 13, 2025 – Artificial Intelligence (AI) has achieved a pivotal breakthrough in the medical field, successfully adjudicating clinical events in cardiovascular trials. This... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Post-Shutdown Jitters: Markets Reel as Government Reopens
The United States government, after an unprecedented 43-day shutdown, officially reopened on Thursday, November 13, 2025, as President Donald Trump signed a funding bill into law. While the resolution... 
Via MarketMinute
Topics Bonds Economy Government
News headline image
Gilead’s Experimental One Pill Regimen Proved Non-Inferior To Multi-Pill Regimens In Treating HIV ↗
The company now plans to submit the data from the study to regulatory authorities. 
Via Stocktwits
News headline image
Explore the S&P500 index on Thursday and find out which stocks are the most active in today's session. ↗
Curious about the most active S&P500 stocks in today's session? Get insights into the stocks that are leading the way in terms of trading volume and market attention. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.